Pilot corpus: NIH-funded biomedical datasets. Any DOI can be scored on demand — network effects sharpen as coverage grows.

Targeting metabolic sensing switch GPR84 on macrophages for cancer immunotherapy

Cancer Immunology Immunotherapy(2024)10.1007/s00262-023-03603-3Source: DataRank Database

Targeting metabolic sensing switch GPR84 on macrophages for cancer immunotherapy is a research paper published in Cancer Immunology Immunotherapy (2024). On theSindex it has a DataRank of 0.373. It has been cited 11 times.

N/A

0.373DataRank · unranked

Scored on demand from live citation data

Open Access11 citations

Download PDF

Cite:

DataRank reads this dataset's downstream impact straight off the citation graph — no black box, no proprietary weighting. How is this computed?

›Methodology & internals

datarank_citation_only_1hop_v6· scope data_onlyMethodology

Pipeline:MetadataData-paper checkEnrichmentCitation networkScoring

Enrichment:Funding (9 grants)Impact (FWCI 1.82)OA: goldTopics (57)IDs (PubMed, PMC, OpenAlex)SDGs (1)

FAIR Checklist

Context only (not used in score)

Findable (1/2)

Has DOI

Accessible (1/2)

Open Access

Interoperable (0/2)

Reusable (0/3)

FAIR checklist signals are shown for context only and do not affect DataRank scoring.

Run a calibrated FAIR evaluation for this paper →

We only score data papers we can read in full — never from an abstract alone.

DataRank Breakdown

Base Score 100%Citation Network 0%

Base Score Contribution

0.373

From this paper's citation signal

Citation Network Contribution

Citation network not refreshed for this result

This paper's DataRank is currently driven only by its base citation score. Citation network data was not refreshed for this result.

Learn more about DataRank methodology →

Authors (16)

Anjun Ma ORCID,Ruohan Zhang ORCID,Chen Yao ORCID,Chelsea Bolyard,Bao Zhao ORCID

Live enrichment

PubMed:38349405 PMC:PMC10864225 OpenAlex:https://openalex.org/W4391774844

Susan G. Komen

Grant: CCR231013713

American Cancer Society

Grant: RSG-103649

NIH

Grant: 1R01CA269984-01A1

Targeting GPR84 to Overcome Macrophage Mediated Resistance to Immunotherapy

NCI NIH HHS

Grant: R01 CA269984

NCI NIH HHS

Grant: P30 CA016058

NHLBI NIH HHS

Grant: R01 HL160581

NHLBI NIH HHS

Grant: R01 HL162909

National Institutes of Health

Grant: 5R01CA269984-03

Targeting GPR84 to Overcome Macrophage Mediated Resistance to Immunotherapy

National Institutes of Health

Grant: 3P30CA016058-15S1

CORE--HORMONE RECEPTOR LABORATORY

FWCI

1.82

Citation Percentile

0.8%

Citation Trend

2024

2025

2026

goldLicense: cc-by

journalhttps://link.springer.com/content/pdf/10.1007/s00262-023-03603-3.pdf

HYBRIDhttps://link.springer.com/content/pdf/10.1007/s00262-023-03603-3.pdf

publisherhttps://link.springer.com/content/pdf/10.1007/s00262-023-03603-3.pdf

publisherhttps://link.springer.com/article/10.1007/s00262-023-03603-3/fulltext.html

journalhttps://doi.org/10.1007/s00262-023-03603-3

Fields of Study

Immune cells in cancerPhagocytosis and Immune RegulationCancer Immunotherapy and BiomarkersMedicineBiology0301 basic medicine0303 health sciences03 medical and health sciencesAnimalsMiceCarcinogenesisFatty AcidsImmune Checkpoint InhibitorsImmunotherapyMacrophagesTumor MicroenvironmentTumor-Associated MacrophagesReceptors, G-Protein-Coupled

MeSH Terms

Immune Checkpoint InhibitorsTumor-Associated MacrophagesAnimalsFatty AcidsImmunotherapyMacrophagesReceptors, G-Protein-CoupledMiceTumor MicroenvironmentCarcinogenesis

Keywords

Tumor microenvironmentCancer researchMacrophage polarizationImmune checkpointImmunotherapyCancer cellImmune systemCancer immunotherapyReceptorBlockadeChemistryCancerBiologyMacrophageCell biologyImmunologyIn vitroBiochemistryTumor-associated macrophageImmunometabolsimCarcinogenesisResearchMacrophagesFatty AcidsReceptors, G-Protein-CoupledMiceTumor-Associated MacrophagesAnimalsImmune Checkpoint Inhibitors

Sustainable Development Goals

SDG 0: Good health and well-being